Its because they haven't included the likely profits from being closely involved in the Oxford vaccine in FY 21 forward estimates. They have included the costs only.
Otherwise you are correct in noticing that the headline results do not indicate a company priced for growth.
Its because they haven't included the likely profits from being...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$294.13 |
Change
-0.870(0.29%) |
Mkt cap ! $142.8B | |||
| Open | High | Low | Value | Volume |
| $295.01 | $295.92 | $293.51 | $15.39M | 52.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 27 | $294.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $294.16 | 19 | 2 |
View Market Depth
| Last trade - 10.38am 10/10/2024 (20 minute delay) ? |
| CSL (ASX) Chart |